Real-world overall survival in second-line maintenance niraparib monotherapy versus active surveillance in patients with wild-type recurrent ovarian cancer by Robert L. Coleman, Jessica A. Perhanidis, Linda Kalilani, Nicole M. Zimmerman, Amanda Golembesky, Kathleen N. Moore

Get full text

Strategies for prevention and management of ocular events occurring with mirvetuximab soravtansine by Andrew Hendershot, Mark Slabaugh, Kamran M. Riaz, Kathleen N. Moore, David M. O'Malley, Ursula Matulonis, Gottfried E. Konecny

Get full text

Neoadjuvant immunotherapy of locoregionally advanced solid tumors by John Wright, Patrick M Forde, Robert L Ferris, Ahmad A Tarhini, Kathleen N Moore, Jennifer R Eads, Valerie Tatard-Leitman

Get full text

Overcoming the challenges of drug development in platinum-resistant ovarian cancer by Ramez N. Eskander, Kathleen N. Moore, Bradley J. Monk, Thomas J. Herzog, Christina M. Annunziata, David M. O’Malley, Robert L. Coleman

Get full text

Symptom trajectories over time by cannabis use status among patients undergoing cancer treatment by Taylor Niznik, Laili K. Boozary, Meng Chen, Amy M. Cohn, Susanna V. Ulahannan, Christina E. Henson, Adam C. Alexander, Kathleen N. Moore, Laura L. Holman, Lurdes Queimado, Darla E. Kendzor

Get full text